28 October 2009 Business
Industry news, November 2009
Thermo Fisher Scientific has agreed to sell three of its analytical technology divisions to GE Healthcare for just over $1 billion (£645 million). The move is intended to satisfy the demands of US competition regulators and speed up final approval for Thermo’s ongoing takeover of Life Technologies.
GE will take over Thermo’s cell culture supplies, gene modulation and magnetic beads businesses, which are expected to generate combined sales in the region of $250 million for 2013.
19 April 2013 Business
Equipment suppliers unite, bringing Thermo into life sciences and sequencing markets
26 August 2014 Research
An artificial protein that self-assembles around and protects DNA could be ideal for gene therapy, nanomachines and synthetic...
23 July 2014 Comments
Giving the world carbon-free energy means putting nuclear energy back on the agenda, says James Hansen